1.CAS NO:1310726-60-3 Upadacitinib USDMF would be available by 2023
2.CAS NO:808118-40-3 Roxadustat USDMF would be available by 2022
3.CAS NO:81409-90-7 Cabergoline USDMF would be available by 2022
4.CAS NO:1260141-27-2 Vonoprazan Fumarate DMF is available
5.CAS NO:832720-36-2 Elagolix Sodium DMF is available
